Current position:Home > Selling > Levodopa

Levodopa

  • CAS No.: 59-92-7
  • Min quantity: 1400 Kilograms
  • Weight: 197.18794
  • Formula: C9H11NO4
  • Place of Orign: zhuzhou,Hunan,China
Ms.Benjamin Yan

Supplier Details

View the Seller's Store
Product Details
Company Profile

Item specifics

  • Product Name.:Levodopa
  • CAS No: 59-92-7
  • Weight: 197.18794
  • Formula: C9H11NO4
  • Melting Point: 295 ºC
  • Boiling Point: 448.4 °C at 760 mmHg
  • Density: 1.468g/cm3

Details

Levodopa

Alias: ;HYDROXYTYROSINEL-DOPA, L-3-HYDROXYTYROSINE

Product Details:
Place of Origin: China
Certification: ISO9001
Brand:YuanCheng
Payment & Shipping Terms:

Minimum Order Quantity:1kg
Supply Ability:500kg/month
Delivery Time:within 24 hours after payment
Payment Terms:Western Union, MoneyGram, T/T
Package:25 kg/drum
Appearance:White crystalline Powder

Product Description:

CAS: 59-92-7
EINECS: 200-445-2
M.F.: C9H11NO4
M.W. : 197.19
Purity:99%
M.P.: 276-278 °C
M.S.:


L-DOPAis a chemical that is made and used as part of the normal biology of humans, some animals and plants. Some animals and humans make it via biosynthesis from the amino acid L-tyrosine. L-DOPA is the precursor to the neurotransmitters dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline) collectively known as catecholamines. L-DOPA can be manufactured and in its pure form is sold as a psychoactive drug with the INN levodopa; trade names include Sinemet, Parcopa, Atamet, Stalevo, Madopar, and Prolopa. As a drug it is used in the clinical treatment of Parkinson's disease and dopamine-responsive dystonia.

L-DOPA crosses the protective blood-brain barrier, whereas dopamine itself cannot. Thus, L-DOPA is used to increase dopamine concentrations in the treatment of Parkinson's disease and dopamine-responsive dystonia. This treatment was made practical and proven clinically by George Cotzias and his coworkers, for which they won the 1969 Lasker Prize.[1][2] Once L-DOPA has entered the central nervous system, it is converted into dopamine by the enzyme aromatic L-amino acid decarboxylase, also known as DOPA decarboxylase (DDC). Pyridoxal phosphate (vitamin B6) is a required cofactor in this reaction, and may occasionally be administered along with L-DOPA, usually in the form of pyridoxine.

Besides the central nervous system, L-DOPA is also converted into dopamine from within the peripheral nervous system. The resulting hyperdopaminergia causes many of the adverse side effects seen with sole L-DOPA administration. To bypass these effects, it is standard clinical practice to co-administer (with L-DOPA) a peripheral DOPA decarboxylase inhibitor (DDCI) such as carbidopa (medicines combining L-DOPA and carbidopa are branded as Lodosyn, Sinemet, Parcopa, Atamet, Stalevo) or with a benserazide (combination medicines are branded Madopar, Prolopa), to prevent the peripheral synthesis of dopamine from L-DOPA. Co-administration of pyridoxine without a DDCI accelerates the peripheral decarboxylation of L-DOPA to such an extent that it negates the effects of L-DOPA administration, a phenomenon that historically caused great confusion.

Permanent link:

Send message to this supplier

CAS No:59-92-7 (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid

Ms.Benjamin Yan
View the Seller's Store
- Enter between 20 to 3,000 characters. English only.
Your message must be between 20-2000 characters.English only.